These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37024851)

  • 1. CYP2C19 loss-of-function is associated with increased risk of hypertension in a Hakka population: a case-control study.
    Cai N; Li C; Gu X; Zeng W; Zhong J; Liu J; Zeng G; Zhu J; Hong H
    BMC Cardiovasc Disord; 2023 Apr; 23(1):185. PubMed ID: 37024851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.
    Zhong Z; Hou J; Zhang Q; Li B; Li C; Liu Z; Yang M; Zhong W; He X; Wu H; Zhong M; Zhao P
    Eur J Clin Pharmacol; 2018 Apr; 74(4):423-431. PubMed ID: 29243114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients.
    Shi Y; Yang Y; Feng M; Ling W; Wei T; Cao Y; Zhong R; Wu H
    Int J Gen Med; 2023; 16():3473-3481. PubMed ID: 37601806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China.
    Zhong Z; Hou J; Li B; Zhang Q; Liu S; Li C; Liu Z; Yang M; Zhong W; Zhao P
    Med Sci Monit; 2017 Dec; 23():6186-6192. PubMed ID: 29288619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese Subjects.
    Song BL; Wan M; Tang D; Sun C; Zhu YB; Linda N; Fan HW; Zou JJ
    Clin Ther; 2018 Jul; 40(7):1170-1178. PubMed ID: 30017169
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Xie J; Pan T; Luo W; Zhang S; Fang Y; Xu Z
    Int J Gen Med; 2023; 16():5139-5146. PubMed ID: 37954650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia.
    Lee J; Cheng N; Tai H; Jimmy Juang J; Wu C; Lin L; Hwang J; Lin J; Chiang F; Tsai C
    Eur J Vasc Endovasc Surg; 2019 Sep; 58(3):373-382. PubMed ID: 31395432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder.
    Akasaka T; Hokimoto S; Sueta D; Tabata N; Sakamoto K; Yamamoto E; Yamamuro M; Tsujita K; Kojima S; Kaikita K; Kajiwara A; Morita K; Oniki K; Saruwatari J; Nakagawa K; Ogata Y; Ogawa H
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1494-500. PubMed ID: 26993229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.
    Hokimoto S; Chitose T; Mizobe M; Akasaka T; Arima Y; Kaikita K; Iwashita S; Morita K; Miyazaki H; Oniki K; Matsui K; Nakagawa K; Ogawa H
    Eur J Clin Pharmacol; 2014 Jun; 70(6):667-73. PubMed ID: 24763934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis.
    Yan Y; Hao R; Zhao X; Xia X; Wang L; Li X
    J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106798. PubMed ID: 36215918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2C19-rs4986893 confers risk to major depressive disorder and bipolar disorder in the Han Chinese population whereas ABCB1-rs1045642 acts as a protective factor.
    Zhang T; Rao Q; Lin K; He Y; Cai J; Yang M; Xu Y; Hou L; Lin Y; Liu H
    BMC Psychiatry; 2023 Jan; 23(1):69. PubMed ID: 36698099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.
    Yadav SS; Ruwali M; Shah PP; Mathur N; Singh RL; Pant MC; Parmar D
    Mutat Res; 2008 Sep; 644(1-2):31-7. PubMed ID: 18644391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina.
    Akasaka T; Sueta D; Arima Y; Tabata N; Takashio S; Izumiya Y; Yamamoto E; Yamamuro M; Tsujita K; Kojima S; Kaikita K; Kajiwara A; Morita K; Oniki K; Saruwatari J; Nakagawa K; Ogata Y; Matsui K; Hokimoto S
    Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1409-H1415. PubMed ID: 27663770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysis.
    Chang M; Tybring G; Dahl ML; Lindh JD
    Clin Pharmacokinet; 2014 Sep; 53(9):801-11. PubMed ID: 25154506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the INNOVANCE PFA P2Y assay and its association with CYP2C19 genotypes.
    Kim H; Kim Y; Koh YS; Lee HK; Chae H; Jekarl DW; Lee JM; Shin WS; Kim TH
    Platelets; 2015; 26(2):148-53. PubMed ID: 24617511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.
    Subraja K; Dkhar SA; Priyadharsini R; Ravindra BK; Shewade DG; Satheesh S; Sridhar MG; Narayan SK; Adithan C
    Eur J Clin Pharmacol; 2013 Mar; 69(3):415-22. PubMed ID: 22955794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between genetic polymorphism of CYP2C19 and the efficacy of
    Luo LL; Chen B; Shu XL; Zheng W; Long G; Jiang MZ
    Zhonghua Er Ke Za Zhi; 2023 Jul; 61(7):600-605. PubMed ID: 37385802
    [No Abstract]   [Full Text] [Related]  

  • 18. Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy.
    Saeed LH; Mayet AY
    Int J Med Sci; 2013; 10(11):1497-502. PubMed ID: 24046523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction].
    Qi L; Liang W; Qiao H; Wang R; Han J; Xing X; Hu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jan; 38(1):87-91. PubMed ID: 33423267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer.
    Jainan W; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(24):10957-60. PubMed ID: 25605208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.